# DrugBank

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/drugbank

- Industry: Software
- Headquarters: Edmonton, Canada
- Website: www.drugbank.com
- Total disclosed funding: $7.2M
- Latest round: Seed (Apr 11, 2022)
- Investors on record: 5

## About

Based in Alberta, Canada, and founded in 2015 by its CEO Mike Wilson and CTO Craig Knox, OMx Personal Health Analytics Inc, trading as DrugBank, operates as a drug knowledge platform that provides structured drug data solutions and products. In April 2022, OMx Personal Health Analytics, Inc. raised CAD 9 million in seed funding led by new investor Brightspark Ventures, with participation from other new investors Amplitude and Theodorus. Returning investors Accelerate Fund and BoxOne Ventures also participated in the round. As of June 2022, the company has more than 12 million global users across more than 24 countries.

OMx Personal Health Analytics Inc offers an artificial intelligence-based clinical API that organizes drug labels into patient-centric and physician-oriented modules and has various features such as drug search, drug-drug interaction checker, drug allergy and cross-sensitive information, and US drug labels API. In addition, the company offers commercial drug datasets and academic drug datasets. The company's client base includes GenXys, Merck, Cradle solution, National Institute of Health.

The company will use the seed funding to scale up its team while investing in its AI-powered technologies and strategic partnerships.

## Funding rounds

- Seed, Apr 11, 2022, $7.2M — Yaletown Partners, Brightspark Ventures, Seido Capital, Amplitude, BoxOne Ventures

## Investors

- Yaletown Partners (https://capitalatlas.ai/funds/yaletown-partners) — Seed
- Brightspark Ventures (https://capitalatlas.ai/funds/brightspark-ventures) — Seed
- Seido Capital (https://capitalatlas.ai/funds/seido-capital) — Seed
- Amplitude (https://capitalatlas.ai/funds/amplitude) — Seed
- BoxOne Ventures (https://capitalatlas.ai/funds/boxone-ventures) — Seed